AGREEMENT CONTAINING CONSENT ORDERSAgreement Containing Consent Orders • February 19th, 2016
The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition by Proposed Respondent Lupin Ltd., (“Lupin”) of the voting securities of Proposed Respondent Gavis Pharmaceuticals LLC (“Gavis”) and Novel Laboratories, Inc. (“Novel”) (Lupin, Gavis, and Novel are hereinafter collectively referred to as “Proposed Respondents”), and it now appearing that Proposed Respondents are willing to enter into this Agreement Containing Consent Orders (“Consent Agreement”) to divest certain assets and providing for other relief:
AGREEMENT CONTAINING CONSENT ORDERSAgreement Containing Consent Orders • August 16th, 2021
The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition by Proposed Respondent Impax Laboratories, Inc. (“Impax”) of the voting securities of Proposed Respondent Tower Holdings, Inc. (“Tower”) and Lineage Therapeutics, Inc. (“Lineage”) from Proposed Respondent RoundTable Healthcare Partners II, LP (“RoundTable”) (Impax, Tower, and RoundTable are hereinafter collectively referred to as “Proposed Respondents”), and it now appearing that Proposed Respondents are willing to enter into this Agreement Containing Consent Orders (“Consent Agreement”) to divest certain assets and providing for other relief:
In the Matter of ) ) Chevron Corporation, ) a corporation, ) FTC File No. 011 0011 ) and ) ) Texaco Inc., ) a corporation. ) ) ------------------------------------Agreement Containing Consent Orders • September 12th, 2001 • Texaco Inc • Petroleum refining • Delaware
AGREEMENT CONTAINING CONSENT ORDERSAgreement Containing Consent Orders • July 20th, 2017
The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition by Baxter International Inc. of the voting securities of certain entities (defined in the attached proposed Decision and Order as “Claris Generic Pharmaceutical Entities”) and related assets from Claris Lifesciences Limited (“Claris”) and their ultimate parent entity Mr. Arjun Handa (Baxter, Claris, and Mr. Handa, hereinafter collectively referred to as “Proposed Respondents”), and it now appearing that Proposed Respondents are willing to enter into this Agreement Containing Consent Orders (“Consent Agreement”) to divest certain assets and providing for other relief:
AGREEMENT CONTAINING CONSENT ORDERSAgreement Containing Consent Orders • September 9th, 2010
The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition by Air Products and Chemicals, Inc. (hereinafter “Proposed Respondent”) of certain voting securities of Airgas, Inc. (“Airgas”), and it now appearing that Proposed Respondent is willing to enter into this Agreement Containing Consent Orders (“Consent Agreement”) to divest certain assets and providing for other relief:
